Compare
Ensign vs Tenet Health (ENSG vs THC)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Ensign (ENSG) returned -4.7% and Tenet Health (THC) +35.8%; so far this year the figures are +4.0% and +42.6%.
Tenet Health is the larger company by market value, about 2.1 times the size of Ensign.
On trailing earnings, ENSG trades at 26.9 times and THC at 8.2 times.
Revenue grew +17.5% at ENSG and +6.2% at THC over the last year.
ENSG yields 0.14%. THC pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ENSG | THC | |
|---|---|---|
| Price | $181.08 | $283.33 |
| 1-day | -0.72% | -1.09% |
| YTD | +3.95% | +42.58% |
| 1 year | -4.66% | +35.81% |
| 3 years | +87.63% | +433.68% |
| Market cap | $10.6B | $22.6B |
| P/E | 26.9 | 8.2 |
| P/S | 1.87 | 1.02 |
| P/B | 4.13 | 4.14 |
| Revenue growth | +17.50% | +6.20% |
| EPS growth | +20.20% | +134.50% |
| Gross margin % | 20.8 | — |
| Net margin % | 7.1 | 13.1 |
| ROE % | 15.6 | 53.3 |
| Debt / equity | 0.08 | 2.43 |
| FCF yield % | 6.6 | 14.8 |
| Dividend yield % | 0.14 | — |
| Beta | 0.06 | 0.55 |
| RSI (14) | 53.1 | 60.2 |
| Technical rating |